Dr. Robert Woodward, United States
Will replace Pascal Pedini for Q&A

Dr. Adela D Mattiazzi, United States
High levels of Donor Derived Cell-Free DNA in the early post-transplant phase indicates injury independent of renal function status

Dr. Anil Paramesh, United States
Longitudinal Analysis Of Donor-derived Cell-free DNA (dd-cfDNA) In En-bloc Kidney Transplantation

Dr. Reginald Y Gohh, United States
Donor-derived Cell-free DNA (dd-cfDNA) For Assessment Of Response After Treatment Of Allograft Rejection

Giselle Guerra, United States
Identification of the Source of Donor Derived Cell-Free DNA in a Kidney-Pancreas Transplant Recipient: Case Study

Mr. Evangelos Mantios, Greece
Assessment of donor derived cell free DNA (ddcfDNA) at surveillance and at clinical suspicion of acute rejection in renal transplantation

Dr. Alejandra M. Mena-Gutierrez, United States
Donor-Derived Cell-Free DNA Testing in Kidney Transplantation: Do One-Month Values Have Any Prognostic Significance?

Dr. Bogdan Obrisca, Romania
Elevated donor-derived cell-free DNA associates with subsequent decline of allograft function

Dr. Pascal Pedini, France
Donor-derived cell-free DNA surveillance level kinetics after lung transplantation: experience from a single-center feasibility study

Dr. Pedro Ventura-Aguiar, Spain
Dynamic of donor derived cell‐free DNA and blood gene expression after pancreas transplantation

Dr. Nicole Ali, United States
Longitudinal surveillance of a kidney transplant recipient during pregnancy using quantification of fetal and donor-derived cell-free DNA

Dr. Nicole Ali, United States
Kinetics of dd-cfDNA in kidney transplant recipients following SARS-CoV-2 vaccination booster administration.